Author: BlackMask Financial

Posted on

S. Korea biggest daily spike 2,223 new COVID-19 cases

South Korea on Wednesday confirmed more new cases of COVID-19 in a single day than it has seen so far during this pandemic. Making matters even more concerning, experts say the coming weeks could be even worse. This is the first time that the country has logged more than 2-thousand Covid-19 infections in a single 24-hour period.
South Korea on Wednesday reported 2,223 new Covid-19 infections. The greater Seoul area saw the highest number of local infections yet, with the local caseload at 1,405.Health authorities say the Delta variant is driving up cases, with clusters erupting in workplaces, indoor sports facilities, churches, and at care hospitals.
But the worst is yet to come.

Experts last month have already projected that at the virus’ current reproductive rate,.. the nation will see 2,5-hundred to 3-thousand new cases a day by late August.

Experts are also worried about the enormous strain this will put on healthcare services, saying a sudden rise could overwhelm medical staff and supplies. In that case, what can be done – that hasn’t already been attempted – to try and curb the spread. Health authorities say that in order to protect our lives and the economy, we first need to decrease the risk of infection by cutting down on travel and social gatherings. But we can’t only rely on social distancing to fix the problem. Vaccinations are of the utmost importance as well. “We need to do our best to protect the most vulnerable people and facilities by curbing the infection spread through prevention methods, and also by raising the vaccination rates.” There will be a boost in the supply of Pfizer’s vaccines today, with six million additional doses arriving. Nick Note: Unfortunately this is what should heave been done 6 months ago. Social distancing and toilet paper mask will not stop this monster. And their is not enough time to get their populations 2 doses of effective vaccines….. Their only solution is testing on a mass scale and extreme lock down which the masses will never accept. So the great culling of stupis people has begun…

 

Posted on

Top Japan health adviser wants stricter COVID-19 measures for about two weeks

OKYO -Japan’s top health adviser said on Thursday he would request stricter emergency measures for about two weeks to tackle a spike in COVID-19 cases in Tokyo and other areas.

Shigeru Omi told reporters the contagion should treated as a natural disaster and he called on the government to increase testing to find and contain the spread.

A few days after the end of the Tokyo Olympics, the capital reported 4,989 new daily cases on Thursday, down slightly from record 5,042 last week. The new number of patients with serious symptoms increased to an all-time daily high of 218. There has been no evidence that the Olympics https://www.usnews.com/news/top-news/articles/2021-08-07/olympics-tokyo-feared-games-would-spread-covid-numbers-suggest-that-didnt-happen directly increased case numbers in Japan, but health experts have warned that holding the Games could have encouraged people to relax infection controls. Japan is vaccinating more than 1 million people a day, but it still lags many major economies in inoculating its population. Tokyo is already under a state of emergency, the fourth so far in the pandemic, though some experts have said it should be expanded to cover the whole country. The western prefecture of Osaka reported a record 1,654 new cases on Thursday. Hospital beds are filling up rapidly, mainly with patients in their 40s and 50s, Omi said. To try to break the chain of infection, he said, authorities should try to reduce human mobility to about 50% of the average in July. His comments echoed those of a separate panel of experts who said on Thursday contagion in Tokyo had become uncontrollable.

“The number of new positive cases is rapidly increasing, making it impossible to control the situation,” Norio Ohmagari, a health adviser to the Tokyo Metropolitan Government, told a panel chaired by Governor Yuriko Koike.

Koike urged residents to avoid travel and stay home to slow the transmission of COVID-19, which is causing hospitals to have to forego some standard medical care. Nick Note: In this next wave governments will do anything possible to avoid lock downs making things far worse….. People will be dropping dead  on the streets.

Posted on

WHO: Global virus cases to top 300M in early 2022

The World Health Organization (WHO) warned on Wednesday the global count of infections from COVID-19 will surpass 300 million in early 2022 if the pandemic continues to move in its current direction. WHO Director-General Tedros Adhanom Ghebreyesus stressed the real number of cases is “much higher” as there are many unreported ones. He also called for an urgent donation worth $7.7 billion of vaccines and medical supplies for lower-income countries. “We are all in this together. But the world is not acting like it,” Tedros said. Tedros recently commented on the new spikes in infections around the globe by saying that “hard-won gains in fighting COVID-19 are being lost.”

Director-General of the World Health Organization, Tedros Adhanom, warned on Friday that the number of newly registered COVID-19 cases and deaths continues to climb in numerous countries across the globe. Commenting on new coronavirus variants, Dr. Tedros argued there will be more versions of the virus as long as the spreading lasts. “Hard-won gains in fighting COVID-19 are being lost,” he insisted at WHO’s press briefing. Dr. Tedros concluded by reiterating that the WHO’s goal remains to support every country to vaccinate at least 40% of its population by the end of the year and 70% by the middle of 2022. Nick Note: Enough already about the virus gone wild protect yourself stories. The take here is the markets are virtually completely ignoring the 2 ton Guerrilla   in the room. The spreading plauge like a dark shadow over the planet. Let them enjoy the mindless stock market rally…… While it lasts. Guy like me have great skill at predicting stock market bubbles…. and trading them on the short side. What i always look for is the pin in the room that will burst the balloon. And i think i found it. The coming surge in covid-19 infections that will come this winter flue season….. The rest is relatively simple…..

Posted on

New data on coronavirus vaccine effectiveness

A new preprint study (copy below)  that raises concerns about the mRNA vaccines’ effectiveness against Delta — particularly Pfizer’s — has already grabbed the attention of top Biden administration officials.

The study found the Pfizer vaccine was only 42% effective against infection in July, when the Delta variant was dominant. “If that’s not a wakeup call, I don’t know what is,” a senior Biden official told Axios.

 The study, conducted by nference and the Mayo Clinic, compared the effectiveness of the Pfizer and Moderna vaccines in the Mayo Clinic Health System over time from January to July.

  • Overall, it found that the Moderna vaccine was 86% effective against infection over the study period, and Pfizer’s was 76%. Moderna’s vaccine was 92% effective against hospitalization and Pfizer’s was 85%.
  • But the vaccines’ effectiveness against infection dropped sharply in July, when the Delta variant’s prevalence in Minnesota had risen to over 70%.
  • Moderna was 76% effective against infection, and Pfizer was only 42% effective.
  • The study found similar results in other states. For example, in Florida, the risk of infection in July for people fully vaccinated with Moderna was about 60% lower than for people fully vaccinated with Pfizer.

Although it has yet to be peer-reviewed, the study raises serious questions about both vaccines’ long-term effectiveness, particularly Pfizer’s.

  • It’s unclear whether the results signify a reduction in effectiveness over time, a reduced effectiveness against Delta, or a combination of both.
  • “Based on the data that we have so far, it is a combination of both factors,” said Venky Soundararajan, a lead author of the study. “The Moderna vaccine is likely — very likely — more effective than the Pfizer vaccine in areas where Delta is the dominant strain, and the Pfizer vaccine appears to have a lower durability of effectiveness.”
  • He added that his team is working on a follow-up study that will try to differentiate between the durability of the two vaccines and their effectiveness against Delta.

Yes, but: There has been no data so far that has found either vaccine’s protection against severe disease and death is significantly less against Delta, and the study notes that there doesn’t appear to be much of a difference in complications stemming from breakthrough infections based on which vaccine someone got.

  • And experts cautioned against rushing to conclusions.
  • “This is the kind of surprising finding that needs confirmation before we should accept its validity,” said Cornell virologist John Moore.

Between the lines: The two shots both use mRNA, but there are significant differences between them.

  • For example, Moderna is given in a stronger dose than Pfizer, and there is a slightly different time interval between shots.
  • “There are a few differences between what are known to be similar vaccines …. None of these variables is an obvious smoking gun, although the dosing amount seems the most likely to be a factor,” Moore said.

In a statement, Pfizer said it and BioNTech “expect to be able to develop and produce a tailor-made vaccine against that variant in approximately 100 days after a decision to do so, subject to regulatory approval.” Nick Note: Now will you listen to me… Its foolish to have a librarian that sees the future and not use your library card. Bottom line get a booster shot NOW……. and initiate our personnel protection protocols. Mask up, Vitamin up, isolate, TEST EVERYONE WHO COMES INTO YOUR AIRSPACE. Read the study for yourself below

2021.08.06.21261707v2.full

To Order Test kits, CoronaVits and mask/filters click the link below.

ORDER NOW

Posted on

Stocks hit record highs as Fed tapering concerns ease

NEW YORK/LONDON (Reuters) -Global shares hit record highs Wednesday after data showed U.S. consumer price increases slowed in July, easing concerns that the Federal Reserve will imminently signal a scaling back of bond purchases. The data showed tentative signs inflation had peaked as supply-chain disruptions work their way through the U.S. economy. “This is a more moderate reading than expected, especially on the core,” said Gennadiy Goldberg, an interest rate strategist at TD Securities in New York. Speculation is growing that the Federal Reserve Chair Jerome Powell will signal timings on tapering stimulus at a meeting of central bankers in Jackson Hole, Wyoming, on Aug. 26-28. Stronger-than-expected inflation data may have fuelled talk of an imminent slowing of the Fed’s bond purchases, said Craig Erlam, senior market analyst at OANDA Europe. “Instead, we can all breathe a little easier, albeit safe in the knowledge that tapering is still coming and it’s likely to be announced next month,” he said. U.S. non-farm payrolls figures due in September could also influence tapering if they are particularly strong. It may take a few months more for the U.S. job market to recover enough that the Federal Reserve can reduce its crisis-era support for the economy, Richmond Federal Reserve Bank President Thomas Barkin told Reuters. The MSCI all-country index, a gauge of stocks across the globe, hit a record high and was last trading up 0.25%. The Dow Jones Industrial Average and S&P500 also hit record highs, with sentiment boosted by U.S. lawmakers approving a trillion-dollar infrastructure package Tuesday. The Dow Jones Industrial Average rose 190.03 points, or 0.54%, to 35,454.7, the S&P 500 gained 7.22 points, or 0.16%, to 4,443.97 and the Nasdaq Composite dropped 34.91 points, or 0.24%, to 14,753.18. European shares also hit record highs, clocking their longest winning streak in two months. The STOXX 600 index rose 0.4% to hit an all-time high for an eighth consecutive session.

OIL GAINS, TREASURY YIELDS FALL

Oil gained Wednesday, changing course after the Biden administration said it would not call on U.S. producers to increase crude output, and that efforts to increase OPEC production were a longer-range plan.

U.S. crude oil futures settled at $69.25 per barrel, up 96 cents or 1.41%. Brent crude futures settled at $71.44 per barrel, up 81 cents or 1.15%.

U.S. Treasury yields fell in choppy trading, following a strong 10-year note auction. 10-year yields dropped to session lows, falling from four-week peaks earlier in the session.

Benchmark 10-year notes rose 4/32 in price to yield 1.3303%, down from 1.342% late on Tuesday.

Gold prices jumped following the inflation data.

U.S. gold futures settled up 1.2% at $1,753.30.

Spot gold added 1.4% to $1,752.72 an ounce. U.S. gold futures gained 1.23% to $1,750.40 an ounce.

The dollar index fell 0.189%, with the euro up 0.19% to $1.174.

Asian shares had slipped as fears about further waves of the coronavirus dampened a positive lead from Tuesday’s record close on Wall Street.

MSCI’s broadest index of Asia-Pacific shares outside Japan lost 0.3%.

The Delta variant of the new coronavirus is spreading quickly in many Asian countries, raising fears about local restrictions on travel and other activity damaging the economic recovery. Stocks hit record highs as Fed tapering concerns ease

Posted on

Stocks hit record high as tapering concerns ease

  • CPI data shows inflation moderating in July
  • MSCI all-country index hits record high
  • S&P500, Dow Jones Industrial average hit records
  • European stocks hit new peak
  • Oil dips on report of White House call for more output

NEW YORK/LONDON, Aug 11 (Reuters) – Global shares hit a record high Wednesday after data showed U.S. consumer price increases slowed in July, easing concerns that the Federal Reserve will imminently signal a scaling back of bond purchases. Some investors believed the data showed tentative signs inflation has peaked as supply-chain disruptions work their way through the U.S. economy. “This is a more moderate reading than expected, especially on the core,” said Gennadiy Goldberg, an interest rate strategist at TD Securities in New York. Speculation has mounted that the Fed will signal timings on tapering stimulus at a meeting of central bankers in Jackson Hole, Wyoming, on Aug. 26-28. Stronger-than-expected inflation data would have fuelled that talk. U.S. non-farm payrolls figures due in September could also influence tapering if they are particularly strong.It may take a few months more for the U.S. job market to recover enough that the Federal Reserve can reduce its crisis-era support for the economy, Richmond Federal Reserve Bank President Thomas Barkin told Reuters.  The MSCI all-country index (.MIWD00000PUS), a gauge of stocks across the globe, rose 0.27% to a fresh record high. The Dow Jones Industrial Average (.DJI) and S&P500 (.SPX) also hit record highs in early trade with sentiment boosted by U.S. lawmakers approving a trillion-dollar infrastructure package Tuesday.  The Dow Jones Industrial Average (.DJI) rose 210.55 points, or 0.6%, to 35,475.22, the S&P 500 (.SPX) gained 10.38 points, or 0.23%, to 4,447.13 and the Nasdaq Composite (.IXIC) dropped 11.09 points, or 0.07%, to 14,777.00. In Europe, the STOXX (.STOXX) index of leading companies hit a new peak for an eighth consecutive session as more acquisitions and steady corporate earnings underpinned the economic outlook.

OIL DIPS, DOLLAR GAINS

Crude oil prices fell below $70 a barrel, pressured by a CNBC report that the White House will call on OPEC and its allies to boost production in an effort to combat escalating gasoline prices.

Asian shares had slipped as fears about further waves of the coronavirus dampened a positive lead from Tuesday’s record close on Wall Street.

MSCI’s broadest index of Asia-Pacific shares outside Japan (.MIAPJ0000PUS) lost 0.3%. “What’s clearly separating Asian shares from Wall Street is the difference in vaccination. Low vaccination rates in Asia are proving to be fatal in dealing with the Delta variant,” said Norihiro Fujito, chief investment strategist at Mitsubishi UFJ Morgan Stanley Securities.

The Delta variant of the new coronavirus is spreading quickly in many Asian countries, raising fears about local restrictions on travel and other activity damaging the economic recovery.

Spot gold added 0.8% to $1,742.70 an ounce. U.S. gold futures gained 0.56% to $1,738.50 an ounce. Nick Note: I have a different take on all this. I am sure your not surprised. Inflation at 5+% per year is NOT moderating inflation. And Asia has been 6 months ahead of the US since the start of this pandemic. The plague is still with us and still mutating. The great white hope is a vaccine that half of Americans refuse to take. And a vaccine that is waning and infecting vaccinated people as well as kiliing the ativax people in mass. Did anyomne notice in good ole boy country the fact the hospitals are filling up…. This does not seem to be a hopeful situation to me. I believe we are flirting with disaster. Especially if they are so foolish as to open the schools so we can give the kiddies a new experience. A ventilator at a hospital decorated with Disney characters….

Posted on

Experts Predict What The Next COVID-19 Variants Will Be Like

Alpha, beta, gamma, delta — there have been four COVID-19 variants of concern that have altered the course of the pandemic at different points in the past year and a half. First came the alpha variant, first detected in the United Kingdom, that was more transmissible and caused the surges behind the winter wave of the pandemic. The beta variant came next, triggering outbreaks in South Africa, along with gamma, the variant that took hold of Brazil in January. Now we have delta ― definitely more transmissible, potentially more virulent (though it’s hard to know for sure), and a huge problem for those who remain unvaccinated. Every day brings new concerning headlines about this variant or that mutation, which brings up the natural question: What’s next? To better understand what the next round of variants might look like, we need to take a look at what we’ve learned so far about how this coronavirus changes. Each time the virus infects a new cell, it starts to makes copies of itself — and as it copies, it makes random changes (known as mutations) all over the place. Most mutations aren’t useful and die out, but some can be tolerated and passed on, said Ben Neuman, chief virologist at Texas A&M University’s Global Health Research Complex. Coronaviruses are typically slow changers — they mutate, as any virus does, but they don’t evolve at an alarming rate.

What shocked scientists is the rate of evolution, or how quickly these variants of concern acquired new mutations, according to Nathan Grubaugh, an evolutionary virologist and associate professor of epidemiology at the Yale School of Public Health.

In general, the coronavirus acquires about one or two mutations a month. But the variants of concern have acquired many more mutations much more quickly. Alpha, for example, didn’t just acquire one or two mutations, it picked up 17. The leading hypothesis is that it took a prolonged infection ― probably in an immunocompromised person whose body had a tough time clearing out the virus ― to collect this many mutations so rapidly. From there, the virus spread to somebody else before taking off and shooting through entire communities. According to Grubaugh, the same sort of rapid increase in mutations was identified with the beta variant detected in South Africa and the gamma variant that popped up in Brazil. “This phenomenon that we’re watching, of these variants that arise very quickly, I think caught a lot of us off guard,” Grubaugh said. It’s impossible to predict exactly what future variants will look like, but it’s pretty undeniable that we are going to see new variants emerge. “We haven’t seen the end of variants and we certainly haven’t seen the end of variants that are more transmissible,” Grubaugh said. The development of new variants that rise to the level of concern is actually extremely rare. There have probably been hundreds of thousands of events where a host of new mutations have occurred, but those versions of the virus weren’t very fit so they died out before becoming a variant of concern. Just because the virus evolves, doesn’t mean it’s going to become a variant of concern.

But, when you give the virus so many different opportunities to infect new people, it will inevitably test out new variations. As long as there are people for SARS-CoV-2 to infect, the coronavirus will continue to evolve.

“We know that most of the variants we see emerge from people who are not vaccinated,” said Dirk Dittmer, a virologist at the University of North Carolina’s School of Medicine who is currently working on a variant tracking project in North Carolina. We’ve never seen anything like SARS-CoV-2 before. We’ve never had a pandemic of this scale with so much global mixing. A variant that pops up in Brazil can be in Japan or the United States in a moment’s notice, Grubaugh said. What happens around the globe is going to impact the rest of the world — we aren’t living in a vacuum. This makes it a lot harder to predict what’s going to emerge and where. All that said, the scientists who study the evolution of viruses have some theories. Grubaugh said the next generation of variants could be just like delta, but better at what they do — probably more transmissible, maybe a little bit more successful at reinfecting people who were previously diagnosed with COVID-19. (We know the vaccines produce a more robust immune response than natural infection does.) Neuman predicts somewhat the same. In July, scientists identified that 90% of the SARS-CoV-2 genomes were in the genetic group that fell under the delta variant. Because of that, “the most likely bet is that future strains will look like delta, but with extra changes,” Neuman said.

Gamma and delta both are slightly better at evading immunity compared to alpha and the other earlier variants. To Neuman, it seems reasonable to speculate that the current versions of the vaccines we’re using will eventually be less effective against newer variants.

Continue reading “Experts Predict What The Next COVID-19 Variants Will Be Like”

Posted on

Oil drops on China fuel demand concerns as Delta coronavirus surges

MELBOURNE/SINGAPORE, Aug 11 (Reuters) – Oil prices dipped on Wednesday as analysts cut their forecasts for fuel demand in China following mobility curbs from the spread of the highly infectious Delta variant of the coronavirus, offsetting a bullish outlook for U.S. fuel demand. U.S. West Texas Intermediate (WTI) crude futures fell 18 cents, or 0.3%, to $68.11 a barrel at 0500 GMT, after a 2.7% jump on Tuesday. Brent crude futures dropped 16 cents to $70.47 a barrel, following a 2.3% gain on Tuesday. While both contracts have reclaimed their 100-day daily moving average, a technical chart indicator, they appeared to lack the momentum to stage meaningful revivals as Delta variant fears continued to weigh on markets, said Jeffrey Halley, OANDA’s senior market analyst for Asia Pacific. “Short-term momentum has waned quickly in Asia,” he added. Beijing has imposed travel curbs that will reduce fuel demand in the world’s second-largest oil consumer, prompting Goldman Sachs to cut its demand forecast for China by 1 million barrels per day for the next two months. “Our base case remains that the Delta wave will impact demand – including in China – for only two months, consistent with prior cycles, including most recently in India,” the bank said. Industry data showed U.S. crude oil and gasoline inventories fell last week, while the U.S. Energy Information Administration raised its forecast for fuel demand in 2021 and said consumption in May through July was higher than expected, supporting prices. U.S. crude stocks fell by 816,00 barrels and gasoline stocks fell by 1.1 million barrels in the week ended Aug. 6, according to two market sources, citing data from the American Petroleum Institute. Both drawdowns were a bit smaller than analysts polled by Reuters had expected. The EIA’s monthly report showed that the need for supply from the Organization of the Petroleum Exporting Countries (OPEC) will exceed OPEC supply by 1 million barrels per day in the third quarter and by 300,000 bpd in the fourth quarter of 2021, Commonwealth Bank commodity analyst Vivek Dhar said in a note. “With OECD commercial crude oil stockpiles having dropped back to pre‑COVID levels already, a tightening oil market outlook will likely amplify oil price gains,” he said. Nick Note: This is all well and good. BUT as usual what they forget to tell you is the US is quietly banning foreign travel. AND country after country is shutting down visitors from America. Remember 40% of transportation fuel is consumed by air liens in good times. China and Asia and throw in Australia is sucking shut. The travel and leisure industry have become masters at blowing blue sky up our collective asses.Notice how their are no studies or even data collection of people who become infected after traveling……99% of the corona-19 spread has been by international travelers on airlines. As we speak their are two other mutations ravishing other parts of the world. I am VERY concerned about the The beta variant  outbreaks in South Africa, along with gamma variant that is ravishing Brazil. More on this in other news postings. Yes i believe our test kits will pick up these variants.If they would just halt all air travel for 3 weeks and TEST the shit out of everyone like the china model and these variants will burn themselves out…. We both know that will not happen until its to late

Posted on

US Senate passes $1T bipartisan infrastructure bill

The Senate on Tuesday passed a roughly $1 trillion bipartisan infrastructure deal, a significant win for President Biden and the first step on his top legislative priority. Senators voted 69-30 on the bill, which was spearheaded by a bipartisan group of senators led by Sens. Kyrsten Sinema (D-Ariz.) and Rob Portman (R-Ohio). Nineteen GOP senators voted with all Democrats to pass the legislation. The bill is now heading to the House, where it faces an uncertain future and skepticism from progressives. Speaker Nancy Pelosi (D-Calif.) has vowed she won’t take it up until the Senate passes the second part of its infrastructure two step, a sweeping $3.5 trillion spending package that includes Democrats’ top priorities. But the Senate’s passage of the bipartisan measure on Tuesday gives a victory for Biden and the centrist-minded group that led the legislation, and placed big bets and months of time on the ability to get a bipartisan deal on infrastructure, one of Washington’s long-running legislative white whales. “Congress has talked about truly modernizing our nation’s infrastructure for as long as we can remember. The United States Senate delivered so that we can finally give the American people the safe, reliable, and modern infrastructure they deserve,” Portman, Sinema and the eight other senators who were the core negotiators said in a joint statement after the vote. And underscoring the bill’s importance to the administration, Vice President Harris presided over the vote even though she wasn’t needed to break a tie. The bipartisan deal includes roughly $550 billion in new funding, making it substantially smaller than the $2.6 trillion proposed by Biden earlier this year. It includes money for new investments for infrastructure projects like roads, bridges, broadband, water and rail. According to a Congressional Budget Office (CBO) analysis, the bill would add $256 billion to the deficit, though negotiators argue that “hard” infrastructure projects pay for themselves over time and that CBO didn’t give them full credit for their work.

Continue reading “US Senate passes $1T bipartisan infrastructure bill”

Posted on

Wuhan’s ‘bat woman’ virologist warns more COVID mutations are coming

https://youtu.be/bbYngJYy1GQ

  • Shi Zhengli told Chinese state media that the virus will continue to mutate.
  • The delta variant was first discovered in India and is now the dominant strain of COVID-19.
  • Scientists are also monitoring the lambda variant, which is becoming a prominent strain in South America.

The head of the Wuhan Institute of Virology (WIV) warned that the coronavirus virus will continue to mutate, and urged people to continue to get vaccinated.  Virologist Shi Zhengli told the South China Morning Post that the world will need to prepare to coexist with the virus as it continues to mutate and spread across the globe. “As the number of infected cases has just become too big, this allowed the novel coronavirus more opportunities to mutate and select,” Shi said, according to the South China Morning Post. “New variants will continue to emerge.”

The delta variant has quickly become the dominant COVID-19 strain and is driving a surge in cases around the world. Scientists are also monitoring the lambda variant, which is becoming a prominent strain in South America.

In the U.S., for instance, the delta variant accounts for 75 to 80 percent of cases in the Midwest and upper mountain states as of July, according to data from the Centers for Disease Control and Prevention (CDC) and reporting from Healthline. In July, the CDC warned in an internal document that the delta variant could cause more severe illness and spread as easily as chickenpox, stating: “the war has changed.” Michael Osterholmm, the director for the Center for Infectious Disease Research and Policy at the University of Minnesota, told Newsweek that “a delta on steroids” could also possibly emerge. Shi and her role at the Wuhan Institute of Virology have been met with skepticism from many, particularly among Republican leaders in the U.S. A recent Republican-led investigation from the House Foreign Affairs Committee alleges that Shi, along with other researchers and officials associated with the lab, lied about the origins of COVID-19 and worked to cover up the leak of the virus and the research being done at the lab. Nick Note Shi says more  Mutants are coming… Each one more infectious and deadlier… So far she has been proven right… And she should know at the least she discovered the covid 19 in bats. AND she may even be helping the mutations along with her gene splicing scissors. SO you still need to keep up with your vaccines, CoronaVits and testing……..